Protara Therapeutics Correlations

TARA Stock

USD 2.94 0.34 13.08%

The current 90-days correlation between Protara Therapeutics and Monopar Therapeutics is 0.16 (i.e., Average diversification). The correlation of Protara Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Protara Therapeutics Correlation With Market

Significant diversification

The correlation between Protara Therapeutics and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Protara Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.

Moving together with Protara Stock

0.71	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.7	NAMS	NewAmsterdam Pharma	Pair Corr
0.64	PHVS	Pharvaris BV	Pair Corr
0.77	PMVP	Pmv Pharmaceuticals	Pair Corr
0.79	AGIO	Agios Pharm	Pair Corr
0.9	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.81	AVTE	Aerovate Therapeutics	Pair Corr
0.79	CRVS	Corvus Pharmaceuticals	Pair Corr
0.83	VREX	Varex Imaging Corp	Pair Corr

Moving against Protara Stock

0.84	PEPG	PepGen	Pair Corr
0.77	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.72	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.68	NKTX	Nkarta Inc	Pair Corr
0.52	MREO	Mereo BioPharma Group	Pair Corr
0.51	FDMT	4D Molecular Therapeutics	Pair Corr
0.51	PDSB	PDS Biotechnology Corp	Pair Corr
0.43	IVVD	Invivyd	Pair Corr
0.35	RGNX	Regenxbio	Pair Corr
0.81	COLL	Collegium Pharmaceutical	Pair Corr
0.56	ADAP	Adaptimmune Therapeutics	Pair Corr
0.54	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.53	BDTX	Black Diamond Therap	Pair Corr
0.5	TCBPW	TC BioPharm plc	Pair Corr
0.38	BCYC	Bicycle Therapeutics	Pair Corr
0.36	APTO	Aptose Biosciences	Pair Corr
0.35	SYBX	Synlogic	Pair Corr

Related Correlations Analysis

	VCNX	MNPR	MIRO	SRZN	IKNA	XLO	SRRK	VACC	MTCR
VCNX		-0.33	-0.18	-0.58	-0.01	-0.16	-0.67	-0.1	0.28	VCNX
MNPR	-0.33		0.79	0.07	0.1	0.64	0.68	-0.65	0.47	MNPR
MIRO	-0.18	0.79		-0.02	0.2	0.71	0.69	-0.58	0.71	MIRO
SRZN	-0.58	0.07	-0.02		0.04	0.32	0.27	0.21	-0.35	SRZN
IKNA	-0.01	0.1	0.2	0.04		0.17	0.11	0.16	0.29	IKNA
XLO	-0.16	0.64	0.71	0.32	0.17		0.52	-0.61	0.38	XLO
SRRK	-0.67	0.68	0.69	0.27	0.11	0.52		-0.38	0.33	SRRK
VACC	-0.1	-0.65	-0.58	0.21	0.16	-0.61	-0.38		-0.43	VACC
MTCR	0.28	0.47	0.71	-0.35	0.29	0.38	0.33	-0.43		MTCR
	VCNX	MNPR	MIRO	SRZN	IKNA	XLO	SRRK	VACC	MTCR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MIRO	+ 0.79	MNPR
XLO	+ 0.71	MIRO
MTCR	+ 0.71	MIRO
SRRK	+ 0.69	MIRO
SRRK	+ 0.68	MNPR
XLO	+ 0.64	MNPR

High negative correlations

SRRK	- 0.67	VCNX
VACC	- 0.65	MNPR
VACC	- 0.61	XLO
VACC	- 0.58	MIRO
SRZN	- 0.58	VCNX
MTCR	- 0.43	VACC

Risk-Adjusted Indicators

There is a big difference between Protara Stock performing well and Protara Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Protara Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VCNX	5.96	(0.19)	0.00	(0.29)	0.00	0.00	11.11	(14.00)	54.95
MNPR	20.55	10.48	0.89	(2.36)	7.85	(25.53)	15.93	(9.50)	653.56
MIRO	4.85	0.53	0.05	(0.52)	5.26	(6.37)	11.73	(8.87)	38.49
SRZN	4.71	0.33	0.02	(0.26)	4.88	(5.99)	16.74	(7.91)	33.59
IKNA	1.09	(0.01)	(0.07)	(0.16)	1.39	(1.50)	1.81	(1.74)	13.50
XLO	5.52	0.41	0.04	3.10	6.11	(7.18)	10.81	(10.99)	57.76
SRRK	11.89	6.33	1.10	(0.68)	3.20	(16.09)	10.34	(6.99)	375.97
VACC	1.84	(0.09)	0.00	0.33	0.00	0.00	3.36	(4.63)	14.02
MTCR	2.73	0.26	0.06	0.62	2.46	(5.45)	9.09	(4.44)	21.01

Protara Therapeutics Corporate Management

MBA MPH	VP CoFounder	Profile
Jesse Shefferman	Principal CoFounder	Profile
Jathin MD	Executive Officer	Profile
Justine OMalley	Senior Affairs	Profile
Kristine Rosse	VP Officer	Profile
Patrick MBA	Chief Officer	Profile
Hannah Fry	Principal Controller	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC